The effects of canagliflozin in type 2 diabetes in subgroups defined by population﹕pecific body mass index: Insights from theCANVASProgram andCREDENCEtrial

Post time 6 day(s) ago

journal：Diabetes, Obesity and Metabolism

Authors：Jie Yu; Arianne N. Sweeting; Chris Gianacas; Lauren Houston; Vivian Lee; Robert A. Fletcher; Vlado Perkovic; Qiang Li; Brendon L. Neuen; Otavio Berwanger; Hiddo J. L. Heerspink; Dick de Zeeuw; Clare Arnott

Published date：2023-12-

DOI：10.1111/dom.15267

PDF link：https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.15267

Article link：https://doi.org/10.1111/dom.15267

Article Source：Wiley。

Remark：

Post time 6 day(s) ago

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Wiley] The effects of canagliflozin in type 2 diabetes in subgroups defined by population﹕pecific body mass index: Insights from theCANVASProgram andCREDENCEtrial

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Wiley] The effects of canagliflozin in type 2 diabetes in subgroups defined by population﹕pecific body mass index: Insights from theCANVASProgram andCREDENCEtrial Copy

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Wiley] The effects of canagliflozin in type 2 diabetes in subgroups defined by population﹕pecific body mass index: Insights from theCANVASProgram andCREDENCEtrial